TSSR Tissera Inc. featured news, full reports, and detailed charts
Tissera Inc. (TSSR/TSSR.PK) Wrap Up:
Tissera, Inc., a development stage company, focuses on developing and testing of organ transplantation therapies. The company?s therapies are based on an approach employing organ-specific precursor tissues. It has a license to develop, manufacture, and sell products for solid organ transplantation from embryonic tissue. The company, formerly known as Bert Logic, Inc., was founded in 2000 and is based in Herzlia, Israel.www.tissera.com
2 Employees
Founded in 2000
Tissera Inc. (TSSR:OTC)
|
Market Cap
592.7K
|
Total Revenue
--
|
|
|
EBITDA
1.1M
|
DILUTED EPS TTM
-0.02
|
|
|
P/E
--
|
P/S
--
|
|
|
Return On Asset
-140.53
|
Return On Equity
441.93
|
|
| K = Thousands M = Millions B = Billions | ||
TSSR Top Compensated Officers
Mr. Amos Eiran
Chairman of the Board and Chief Executive Off...
Age: 72
Total Annual Compensation: $212.5K
Mr. Alex Weber
Chief Financial Officer and Chief Accounting ...
Age: 54
Total Annual Compensation: $144.3K
Executives, Board Directors
Compensation as of Fiscal Year 2008.
Key developments for Tissera Inc. (TSSR)
Tissera Deleted From OTCBB
04/1/2009
Tissera Inc.’s common stock will be deleted from OTCBB on April 2, 2009 because of its failure to comply with NASD 6530. The firm will now be added to NBB.
Tissera Inc. will Change its Ticker to TSSRE from TSSR
03/24/2009
Effective March 26, 2009, Tissera Inc. will change its OTCBB stock ticker symbol to TSSRE from TSSR.
Tissera Inc. announced delayed 10-Q filing
03/18/2009
On 03/18/2009, Tissera Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
TSSR Competitors
| Company | Last | Change |
| Geron Corp | $5.73 USD | -0.18 |
| Living Cell Technologies Limited | A$0.29 AUD | 0.00 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | TSSR | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
|
TSSR |
||
|
TSSR transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Tissera Inc.
More news for TSSR
TISSERA INC Financials
PERIOD ENDING31-Oct-0831-Jul-0830-Apr-0831-Jan-08Total Revenue - - - - Cost of Revenue - - - - Gross Profit - - - - Operating ExpensesResearch Development73 132 159 159 Selling General and Administrative121 134 (288)202 Non Recurring - - - - Others - - - - Total Operating Expenses - - - - Operating Income or Loss(194)(266)129 (361)Income from Continuing OperationsTotal Other Income/Expenses Net(35)(1)1 (19)Earnings Before Interest And Taxes(229)1,601 130 (380)Interest Expense - 36 - - Income Before Tax(229)1,565 130 (380)Income Tax Expense(2)4 (7)3 Minority Interest - - - - Net Income From Continuing Ops(227)(307)137 (383)Non-recurring EventsDiscontinued Operations - - - - Extraordinary Items - - - - Effect Of Accounting Changes - - - - ...Click here to read the whole Article (external link)
TISSERA INC Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
TISSERA INC Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
TISSERA INC Files SEC form 10-Q, Quarterly Report
ITEM 2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION Overview We were incorporated under the laws of the State of Washington on May 31, 2000. We develop, test and intend to commercialize solid organ transplantation therapies based on an approach employing organ-specific precursor tissues. Our approach involves harvesting embryonic mammalian tissue at the most appropriate stage after which stem cells commit to becoming organ-specific precursor tissues and transplanting them in target human organ systems. The optimal windows for embryonic tissue transplantation were defined by Prof. Reisner's lab at the Weizman Institute. On October 8, 2003, we entered into a Research and License Agreement with Yeda, whereby Yeda procures the performance of research at the Weizman Institute of Science, under the supervision of Professor Reisner of the Department of Immunology. We have a world wide license that shall expire in each country with respect to each product at the later of (i) the expiration of the patents covering such product in the country of sale, or (ii) 15 years from the date of receipt of FDA New Drug Approval in the United States for such product, or the equivalent in any other country in which the products are sold. We are at development stage and devoting substantially all of our efforts toward conducting R&D activities, raising capital, pursuing regulatory approval, recruiting personnel and building infrastructure. Our former line of business was selling bit error testers. Our license in connection with bit error testers expired in May 2004. We need to raise additional funds on an immediate basis in order to meet our operating requirements and to fulfill our business plan as well as satisfy the working capital loans that mature in January 2009. Since August 2008, we have significantly curtailed all of our product design, development and marketing efforts and released all of our non-management employees. As of the dat...Click here to read the whole Article (external link)
TISSERA INC Files SEC form 10-Q, Quarterly Report
Expired Yahoo - Document Has Expired/e/090122/tssr.pk10-q.html Options that might be of interest: Go to the Yahoo! home page. Go to the Yahoo! Finance home page. Go to the Yahoo! Loan Center. Go to the Yahoo! Insurance Center. Other resources: Message Boards - Stock Chat - Finance Clubs ...Click here to read the whole Article (external link)
Would you like to leave a comment about Tissera Inc. TSSR/TSSR.PK
Find out what social network information about Tissera Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Tissera Inc. there is more great information available at Realpennies.com